Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394

A simplification of the protein assay method of Lowry et al. which is more generally applicable

Peterson, G. L. (1977) · Analytical Biochemistry · doi:10.1016/0003-2697(77)90043-4 · Cited by 8,531

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

Copper, iron and zinc in Alzheimer's disease senile plaques

Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120

Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757

Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability

Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452

Mitochondrial abnormalities in Alzheimer's disease

Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367

Amyloid precursor protein drives down-regulation of mitochondrial oxidative phosphorylation independent of amyloid beta

Lopez Sanchez, M. I. G., Waugh, H. S., Tsatsanis, A., Wong, B. X., Crowston, J. G., Duce, J. A., & Trounce, I. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-10233-0 · Cited by 45

Amyloid precursor protein‐mediated mitochondrial regulation and Alzheimer's disease

Lopez Sanchez, M. I. G., van Wijngaarden, P., & Trounce, I. A. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14554 · Cited by 45

Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes

Moreira, P. I., Cardoso, S. M., Pereira, C., Santos, M. S., & Oliveira, C. R. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824651 · Cited by 44

The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseases

Carvalho, C., Correia, S. C., Cardoso, S., Plácido, A. I., Candeias, E., Duarte, A. I., & Moreira, P. I. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1058160 · Cited by 45

Metal homeostasis in Alzheimer’s disease

White, A. R., Barnham, K. J., & Bush, A. I. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.5.711 · Cited by 42

Nitric Oxide Links Mitochondrial Fission to Alzheimer’s Disease

Westermann, B. (2009) · Science Signaling · doi:10.1126/scisignal.269pe29 · Cited by 43

Synergistic Exacerbation of Mitochondrial and Synaptic Dysfunction and Resultant Learning and Memory Deficit in a Mouse Model of Diabetic Alzheimer's Disease

Wang, Y., Wu, L., Li, J., Du, F., Zhong, C., Chen, J. X., & Yan, S. S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140972 · Cited by 43

Overexpression of Aβ is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model

Li, Q., Mok, S. S., Laughton, K. M., McLean, C., Volitakis, I., Cherny, R. A., Cheung, N. S., White, A. R., & Masters, C. L. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00200.x · Cited by 41

Lessons from two prevalent amyloidoses—what amylin and Aβ have in common

Götz, J., Lim, Y.-A., & Eckert, A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00038 · Cited by 40

Protective Effects of Wogonin against Alzheimer’s Disease by Inhibition of Amyloidogenic Pathway

Huang, D.-S., Yu, Y.-C., Wu, C., & Lin, J. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/3545169 · Cited by 43

Isoforsythiaside Attenuates Alzheimer’s Disease via Regulating Mitochondrial Function Through the PI3K/AKT Pathway

Wang, C., Hao, J., Liu, X. Z., Li, C., Yuan, X., Lee, R. J., Bai, T., & Wang, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165687 · Cited by 41

Mitochondria and Alzheimer's disease

Piaceri, I., Rinnoci, V., Bagnoli, S., Failli, Y., & Sorbi, S. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.033 · Cited by 40

The role of mitochondrial-related nuclear genes in age-related common disease

Li, H., Slone, J. D., & Huang, T. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.04.012 · Cited by 42

An update on the toxicity of Aβ in Alzheimer’s disease

Götz, J. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3016 · Cited by 40

Mitochondrial dysfunction in neocortex and hippocampus of olfactory bulbectomized mice, a model of Alzheimer’s disease

Avetisyan, A. V., Samokhin, A. N., Alexandrova, I., Zinovkin, R. A., Simonyan, R. A., & Бобкова, Н. В. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916060080 · Cited by 38

Interactions between amyloid, amyloid precursor protein, and mitochondria

Wilkins, H. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220518 · Cited by 37

The role of mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease and future strategies for targeted therapy

Li, X., Wu, Z., Si, X., Li, J., Wu, G., & Wang, M. (2025) · European journal of medical research · doi:10.1186/s40001-025-02699-w · Cited by 44

Mitochondrial transcription factor A (TFAM) polymorphisms and risk of late-onset Alzheimer's disease in Han Chinese

Zhang, Q., Yu, J., Wang, P., Chen, W., Wu, Z., Jiang, H. F., & Tan, L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.074 · Cited by 36

Copper in Alzheimer’s disease: too much or too little?

Quinn, J. F., Crane, S., Harris, C., & Wadsworth, T. L. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.27 · Cited by 36

When, where and how? Focus on neuronal calcium dysfunctions in Alzheimer’s Disease

Agostini, M., & Fasolato, C. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.06.008 · Cited by 40

Mitochondrial Toxic Effects of Aβ Through Mitofusins in the Early Pathogenesis of Alzheimer’s Disease

Wu, Z., Zhu, Y., Cao, X., Sun, S., & Zhao, B. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8675-z · Cited by 36

Mitochondrial dysfunction induced by disease relevant AβPP and tau protein mutations

Keil, U., Hauptmann, S., Bonert, A., Scherping, I., Eckert, A., & Müller, W. E. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9206 · Cited by 36

Mitochondrial pathways of copper neurotoxicity: focus on mitochondrial dynamics and mitophagy

Aschner, M., Skalny, A. V., Lu, R., Martins, A. C., Tizabi, Y., Nekhoroshev, S. V., Santamarı́a, A., Sinitskiy, A. I., & Tinkov, A. A. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1504802 · Cited by 39

Agents Complexing Copper as a Therapeutic Strategy for the Treatment of Alzheimers Disease

Squitti, R., & Salustri, C. (2009) · Current Alzheimer Research · doi:10.2174/156720509790147133 · Cited by 35

Bioenergetics and metabolism: a bench to bedside perspective

Swerdlow, R. H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13509 · Cited by 35

Mouse models of mitochondrial complex I dysfunction

Irwin, M. H., Parameshwaran, K., & Pinkert, C. A. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.009 · Cited by 33

Inhibition of poly(ADP-ribose) polymerase-1 alters expression of mitochondria-related genes in PC12 cells: relevance to mitochondrial homeostasis in neurodegenerative disorders

Czapski, G. A., Cieślik, M., Wencel, P. L., Wójtowicz, S., Strosznajder, R. P., & Strosznajder, J. B. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.11.003 · Cited by 33

Characterization of Mitochondrial Dysfunction in the 7PA2 Cell Model of Alzheimer's Disease

Jakovljevic, N. K., Magnifico, M. C., Arese, M., Meli, G., Forte, E., Lecci, A., Manca, A., Giuffrè, A., Mastronicola, D., Sarti, P., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130728 · Cited by 32

Effect of Gender on Mitochondrial Toxicity of Alzheimer's A β Peptide

Viña, J., Lloret, A., Vallés, S. L., Borrás, C., Badía, M.-C., Pallardó, F. V., Sastre, J., & Alonso, M.-D. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1773 · Cited by 33

Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer’s Disease: A Critical Review of New and Old Little Regarded Findings

Atlante, A., & Valenti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115951 · Cited by 33

Metal attenuating therapies in neurodegenerative disease

Mot, A. I., Wedd, A. G., Sinclair, L., Brown, D. R., Collins, S. J., & Brazier, M. W. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.170 · Cited by 32

Impaired mitochondrial energy production and ABC transporter function—A crucial interconnection in dementing proteopathies of the brain

Pahnke, J., Fröhlich, C., Krohn, M., Schumacher, T., & Paarmann, K. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.08.007 · Cited by 35

Oxidative Stress and Alzheimer’s Disease

Singh, S. K., Castellani, R. J., & Perry, G. L. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_10 · Cited by 33

Amino acids variations in Amyloid-β peptides, mitochondrial dysfunction, and new therapies for Alzheimer’s disease

Atamna, H. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9246-2 · Cited by 31

Transient OGG1, APE1, PARP1 and Polβ expression in an Alzheimer's disease mouse model

Lillenes, M. S., Støen, M., Gómez-Muñoz, M., Torp, R., Günther, C., Nilsson, L. N. G., & Tønjum, T. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.09.002 · Cited by 29

Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer’s disease

Bica, L., Crouch, P. J., Cappai, R., & White, A. R. (2008) · Molecular BioSystems · doi:10.1039/b816577g · Cited by 33

Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer’s Disease

Pająk, B., Kania, E., & Orzechowski, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1805304 · Cited by 31

ABAD/17β-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP/PS1 mice

Xiao, X., Chen, Q., Zhu, X., & Wang, Y. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.05.016 · Cited by 31

Mitochondria in aging and age-associated diseases

Pahal, S., Mainali, N., Balasubramaniam, M., Reis, R. J. S., & Ayyadevara, S. (2025) · Mitochondrion · doi:10.1016/j.mito.2025.102022 · Cited by 32

Mitochondria in Alzheimer’s Disease and Diabetes-Associated Neurodegeneration: License to Heal!

Cardoso, S., Correia, S. C., Carvalho, C., & Moreira, P. I. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_3 · Cited by 29

Mitochondrial Translocation of Amyloid Precursor Protein and its Cleaved Products: Relevance to Mitochondrial Dysfunction in Alzheimer's Disease

Anandatheerthavarada, H. K., & Devi, L. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.5.343 · Cited by 28

Systematic review of 31P-magnetic resonance spectroscopy studies of brain high energy phosphates and membrane phospholipids in aging and Alzheimer's disease

Jett, S., Boneu, C., Zarate, C., Carlton, C., Kodancha, V., Nerattini, M., Battista, M., Pahlajani, S. S., Williams, S., Dyke, J. P., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1183228 · Cited by 30

Protective effect of hydroxytyrosol in arsenic‐induced mitochondrial dysfunction in rat brain

Soni, M., Prakāsh, C., Sehwag, S., & Kumar, V. J. (2017) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21906 · Cited by 28

Role of Mitochondrial Dysfunction in the Pathology of Amyloid-β

Huang, Z., Yan, Q., Wang, Y., Zou, Q., Li, J., Liu, Z., & Cai, Z. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200519 · Cited by 28

Mitogen-activated protein kinase signaling pathways promote low-density lipoprotein receptor-related protein 1-mediated internalization of beta-amyloid protein in primary cortical neurons

Yang, W., Ma, K., Qian, Y., Zhang, J.-S., Feng, G.-F., Shi, L., Zhang, Z., & Liu, Z. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.04.013 · Cited by 29

Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease

Feldhaus, P., Fraga, D. B., Ghedim, F. V., De Luca, R. D., Bruna, T. D., Heluany, M., Matos, M. P., Ferreira, G. K., Jeremias, I. C., Heluany, C., et al. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9253-y · Cited by 27

Copper homeostasis and cuproptosis in Alzheimer's disease (Review)

Cong, C., Cong, H., Yao, Y., Bai, Y., & Xu, L. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5613 · Cited by 31

Mitochondrial dysfunction and Alzheimer's disease: New developments

Mancuso, M., Siciliano, G., Filosto, M., & Murri, L. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9203 · Cited by 28

Pathogenic role of mitochondrial amyloid-β peptide

Chen, J. X., & Yan, S. D. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1517 · Cited by 26

Alzheimer's disease: the role of mitochondrial dysfunction and potential new therapies

Hawking, Z. L. (2016) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzw014 · Cited by 29

Clioquinol inhibits peroxide-mediated toxicity through up-regulation of phosphoinositol-3-kinase and inhibition of p53 activity

Filiz, G., Caragounis, A., Bica, L., Du, T., Masters, C. L., Crouch, P. J., & White, A. R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.003 · Cited by 27

Intraneuronal β‐amyloid and its interactions with proteins and subcellular organelles

Penke, B., Tóth, A. M., Földi, I., Szűcs, M., & Janáky, T. (2012) · Electrophoresis · doi:10.1002/elps.201200297 · Cited by 26

The muscle-brain axis in type 2 diabetes: Molecular pathways linking sarcopenia and cognitive decline

Xenos, D., Mancinetti, F., Mecocci, P., & Boccardi, V. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102955 · Cited by 26

Synthesis and evaluation of 8-hydroxyquinolin derivatives substituted with (benzo[d][1,2]selenazol-3(2H)-one) as effective inhibitor of metal-induced Aβ aggregation and antioxidant

Wang, B., Wang, Z., Chen, H., Lu, C., & Li, X. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.08.017 · Cited by 25

Systematic review and meta-analysis on the role of mitochondrial cytochrome c oxidase in Alzheimer’s disease

de Morais, F. M., Ribeiro, A. M., Moreira, F. A., & Silva, P. V. G. (2020) · Acta Neuropsychiatrica · doi:10.1017/neu.2020.43 · Cited by 27

A Pathophysiological Intersection of Diabetes and Alzheimer’s Disease

Čater, M., & Hölter, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911562 · Cited by 25

Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms

Mastaglia, F. L., Rojana-udomsart, A., JAMES, I. R., Needham, M., Day, T. J., Kiers, L., Corbett, J. A., Saunders, A. M., Lutz, M. W., & Roses, A. D. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.09.008 · Cited by 22

Mitochondria are devoid of amyloid β-protein (Aβ)-producing secretases: Evidence for unlikely occurrence within mitochondria of Aβ generation from amyloid precursor protein

Mamada, N., Tanokashira, D., Ishii, K., Tamaoka, A., & Araki, W. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.035 · Cited by 22

Synergistic effects of β-amyloid and ceramide-induced insulin resistance on mitochondrial metabolism in neuronal cells

Kwon, B., Gamache, T., Lee, H., & Querfurth, H. W. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.012 · Cited by 23

Mitochondrial bioenergetics is defective in presymptomatic Tg2576 AD Mice

Varghese, M., Zhao, W., Wang, J., Cheng, A., Qian, X., Chaudhry, A., Ho, L., & Pasinetti, G. M. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0011-8 · Cited by 22

Phosphate Brain Energy Metabolism and Cognition in Alzheimer’s Disease: A Spectroscopy Study Using Whole-Brain Volume-Coil 31Phosphorus Magnetic Resonance Spectroscopy at 7Tesla

Das, N., Ren, J., Spence, J. S., & Chapman, S. B. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.641739 · Cited by 21

Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease

Hoekstra, J. G., Montine, K. S., Zhang, J., & Montine, T. J. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt83 · Cited by 21

Functional adlayers on Au electrodes: some recent applications in hydrogen evolution and oxygen reduction

Chattopadhyay, S., Sarkar, A., Chatterjee, S., & Dey, A. (2017) · Journal of Materials Chemistry A · doi:10.1039/c7ta09179f · Cited by 21

Anti-Copper Therapies in Alzheimers Disease: New Concepts

Squitti, R., & Zito, G. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909789104802 · Cited by 20

Modification of Tau by 8-Nitroguanosine 3′,5′-Cyclic Monophosphate (8-Nitro-cGMP)

Yoshitake, J., Soeda, Y., Ida, T., Sumioka, A., Yoshikawa, M., Matsushita, K., Akaike, T., & Takashima, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.734350 · Cited by 20

Neuroprotective actions of leptin facilitated through balancing mitochondrial morphology and improving mitochondrial function

Cheng, Y., Buchan, M. J., Vitanova, K. S., Aitken, L., Gunn‐Moore, F. J., Ramsay, R. R., & Doherty, G. H. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15003 · Cited by 21

Docking Studies and Biological Evaluation of a Potential β-Secretase Inhibitor of 3-Hydroxyhericenone F from Hericium erinaceus

Diling, C., Yong, T., Jian, Y., Chaoqun, Z., Shuai, O., & Yizhen, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00219 · Cited by 21

The Rationale for Insulin Therapy in Alzheimer’s Disease

Ribarič, S. (2016) · Molecules · doi:10.3390/molecules21060689 · Cited by 20

Effect of melatonin on Aβ42 induced changes in the mitochondrial function related to Alzheimer’s disease in Drosophila melanogaster

Khatoon, R., Rasheed, M. Z., Rawat, M., Alam, M. M., Tabassum, H., & Parvez, S. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134376 · Cited by 18

Neurodegenerative disorders: Dysregulation of a carefully maintained balance?

Swart, C., Haylett, W. L., Kinnear, C. J., Johnson, G., Bardien, S., & Loos, B. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.003 · Cited by 19

Striatal oxidative damages and neuroinflammation correlate with progression and survival of Lewy body and Alzheimer diseases

Xu, J., Li, H., & Knight, W. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.322463 · Cited by 16

The importance of controlling in vitro oxygen tension to accurately model in vivo neurophysiology

Bordt, E. A. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.10.008 · Cited by 15

Intracellular Ion Channel CLIC1: Involvement in Microglia-Mediated β-Amyloid Peptide(1-42) Neurotoxicity

Skaper, S. D., Facci, L., & Giusti, P. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1084-2 · Cited by 16

Altering Mitochondrial Dysfunction as an Approach to Treating Alzheimer’s Disease

Colca, J. R., & Feinstein, D. L. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00005-2 · Cited by 14

Association of N-Acetylaspartate and Cerebrospinal Fluid Aβ42 in Dementia

Jessen, F., Lewczuk, P., Gür, O., Block, W., Ende, G., Frölich, L., Hammen, T., Arlt, S., Kornhuber, J., Kucinski, T., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110398 · Cited by 14

Targeting Mitochondrial Metal Dyshomeostasis for the Treatment of Neurodegeneration

Liddell, J. R. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.19 · Cited by 13

Protective effects of clioquinol on human neuronal-like cells: a new formulation of clioquinol-loaded PLGA microspheres for Alzheimer’s disease

Barcia, E., Salama, A., Fernández-Carballido, A. M., & Negro, S. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.523789 · Cited by 13

Metal Binding to Aβ Peptides Inhibits Interaction with Cytochrome c : Insights from Abiological Constructs

Sarkar, A., Sengupta, K., Chatterjee, S., Seal, M., Faller, P., Dey, S. G., & Dey, A. (2018) · ACS Omega · doi:10.1021/acsomega.8b01736 · Cited by 12

Atorvastatin Improves Mitochondrial Function and Prevents Oxidative Stress in Hippocampus Following Amyloid-β1–40 Intracerebroventricular Administration in Mice

Mancini, G., Martins, W. C., de Oliveira, J., Bem, A. F. D., & Tasca, C. I. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02026-w · Cited by 12

Biometals and Alzheimer’s Disease

Mot, A. I., & Crouch, P. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00001-4 · Cited by 11

FLZ inhibited γ-secretase selectively and decreased Aβ mitochondrial production in APP-SH-SY5Y cells

Ye, X., Tai, W., Bao, X., Chen, X., & Zhang, D. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0918-4 · Cited by 10

Therapeutic Approaches to Delay the Onset of Alzheimer's Disease

Kumar, R., & Atamna, H. (2011) · Journal of Aging Research · doi:10.4061/2011/820903 · Cited by 10

Alterations of Mitochondria and Golgi Apparatus Are Related to Synaptic Pathology in Alzheimer's Disease

Stavros, J. (2013) · InTech eBooks · doi:10.5772/56079 · Cited by 9

The Other Side of Alzheimer’s Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers

Argentati, C., Tortorella, I., Bazzucchi, M., Emiliani, C., Morena, F., & Martino, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030115 · Cited by 10

Advances in our Understanding of Neurodegeneration

Jellinger, K. A. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50142-3 · Cited by 9

Molecular Determinants of Alzheimer’s Disease Aβ Peptide Neurotoxicity

Cappai, R., & Barnham, K. J. (2007) · Future Neurology · doi:10.2217/14796708.2.4.397 · Cited by 9

Photo-Induced Cross-Linking of Unmodified α-Synuclein Oligomers

Ortigosa-Pascual, L., Leiding, T., Linse, S. S., & Pálmadóttir, T. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00326 · Cited by 8

Mitochondrial Medicine: The Central Role of Cellular Energetic Depression and Mitochondria in Cell Pathophysiology

Seppet, E. K., Gizatullina, Z. Z., Trumbeckaitė, S., Zierz, S., Striggow, F., & Gellerich, F. N. (2007) · Wiley eBooks · doi:10.1002/9783527621095.ch15 · Cited by 8

Mitochondrial Medicine

Wallace, D. C., Lott, M. T., & Procaccio, V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00013-6 · Cited by 8

Mitochondria in Neurodegeneration

Swerdlow, R. H. (2011) · Advances in neurobiology · doi:10.1007/978-1-4614-1788-0_30 · Cited by 7

Platelets in Alzheimer’s Disease

Plagg, B., & Humpel, C. (2015) · InTech eBooks · doi:10.5772/60535 · Cited by 7

Neurotoxicity of copper and copper nanoparticles

Joshi, A., Farber, K., & Scheiber, I. F. (2021) · Advances in neurotoxicology · doi:10.1016/bs.ant.2020.11.001 · Cited by 6

Retinal cell apoptosis

Borrie, S. C., Duggan, J., & Cordeiro, M. F. (2009) · Expert Review of Ophthalmology · doi:10.1586/17469899.4.1.27 · Cited by 6

Mitochondria and Alzheimer’s Disease

Balogiannis, S. (2014) · Journal of Neurology & Stroke · doi:10.15406/jnsk.2014.01.00028 · Cited by 4

Role of Mitochondria in Neurodegenerative Diseases: The Dark Side of the “Energy Factory”

Correia, S. C., & Moreira, P. I. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_11 · Cited by 5

Neurodegenerative diseases

Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00004-2 · Cited by 6

Protein S-sulfhydration: Mechanisms and therapeutic implications in Alzheimer's disease and Parkinson's disease

Jinfen, G., Shi, C., Yu, C., Wang, Y., & He, M. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.01.033 · Cited by 4

Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets

Sharma, Y., Gupta, J. K., Babu, M. A., Singh, S., & Sindhu, R. K. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02269-5 · Cited by 6

Examining the Interactome of Huperzine A by Magnetic Biopanning

Guo, W., Liu, S., Peng, J., Wei, X., Sun, Y., Qiu, Y., Gao, G., Wang, P., & Xu, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037098 · Cited by 4

Membrane‐targeted strategies for modulating APP and Aβ‐mediated toxicity

Price, K. A., Crouch, P. J., Donnelly, P. S., Masters, C. L., White, A. R., & Curtain, C. C. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00642.x · Cited by 4

Copper‐dependent inhibition of cytochrome c oxidase by Aβ1−42 requires reduced methionine at residue 35 of the Aβ peptide

Crouch, P. J., Barnham, K. J., Duce, J. A., Blake, R. E., Masters, C. L., & Trounce, I. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04050.x · Cited by 46

Amyloid-b Peptide Binds to Cytochrome C Oxidase Subunit 1

Fern, L., Hern, O., Mena, R., Vazquez-ramirez, R., Kubli‐Garfias, C., Cribbs, D. H., Manoutcharian, K., & Gevorkian, G. (2012)

P2‐130: Beta‐amyloid peptide 1‐42 binds to N‐terminal fragment of cytochrome C oxidase subunit 1 (COX1)

Hernandez, L. G., Luna‐Muñoz, J., Acero, G., Vázquez‐Ramírez, R., & Gevorkian, G. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.835

Amyloid-β Peptide Binds to Cytochrome C Oxidase Subunit 1

Hernández-Zimbrón, L. F., Luna‐Muñoz, J., Mena, R., Vázquez‐Ramírez, R., Kubli‐Garfias, C., Cribbs, D. H., Manoutcharian, K., & Gevorkian, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042344 · Cited by 93

Amyloid-beta Peptide Binds to Cytochrome C Oxidase Subunit 1

Hernandez-Zimbron, L. F., Luna-Muoz, J., Mena, R., Vazquez-Ramirez, R., Kubli‐Garfias, C., Cribbs, D. H., Manoutcharian, K., & Gevorkian, G. (2012) · eScholarship (California Digital Library)